Argent Trust’s GSK GSK Stock Holding History

Argent Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.06M	Buy	21,759 +60	+0.3%	+$2.79K	0.29%	90
2017 Q4	$962K	Sell	21,699 -1,208	-5%	-$55.8K	0.26%	94
2017 Q3	$1.16M	Buy	22,907 +2,628	+13%	+$133K	0.32%	83
2017 Q2	$1.09M	Buy	20,279 +1,341	+7%	+$71.5K	0.31%	89
2017 Q1	$998K	Buy	18,938 +437	+2%	+$22.2K	0.28%	91
2016 Q4	$890K	Sell	18,501 -2,169	-10%	-$107K	0.26%	94
2016 Q3	$1.11M	Sell	20,670 -1,313	-6%	-$72K	0.34%	77
2016 Q2	$1.19M	Buy	21,983 +1,484	+7%	+$78.2K	0.37%	73
2016 Q1	$1.04M	Buy	20,499 +657	+3%	+$32.7K	0.33%	82
2015 Q4	$1M	Buy	19,842 +9,920	+100%	+$506K	0.33%	82
2015 Q3	$477K	Buy	9,922 +374	+4%	+$19.5K	0.54%	46
2015 Q2	$497K	Buy	9,548 +1,589	+20%	+$89.5K	0.49%	45
2015 Q1	$459K	Buy	7,959 +189	+2%	+$10.8K	0.45%	45
2014 Q4	$415K	Buy	+7,770	New	+$435K	0.37%	52

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Argent Trust's GSK Position: Q1 2018 in Review

Argent Trust increased its GSK (GSK) stake by 0.28% in Q1 2018, buying an estimated $2.79K and bringing the position to 21,759 shares worth $1.06M. The position accounts for 0.29% of the portfolio, ranked #90.

Argent Trust first reported a position in GSK in Q4 2014 and has held it in 14 quarters since. The position peaked at $1.19M in Q2 2016. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Argent Trust held 21,759 shares of GSK worth $1.06M as of Q1 2018.
Argent Trust bought 60 GSK shares in Q1 2018, an estimated $2.79K.
GSK made up 0.29% of Argent Trust's portfolio in Q1 2018, its #90 holding.
Argent Trust first reported a position in GSK in Q4 2014 and has held it in 14 quarters since.
Argent Trust's GSK position peaked at $1.19M in Q2 2016.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.